Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.460
-0.010 (-0.40%)
At close: Mar 9, 2026, 4:00 PM EDT
2.465
+0.005 (0.20%)
After-hours: Mar 9, 2026, 7:00 PM EDT
Veru Inc. Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
39.48M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atara Biotherapeutics | 151.93M |
| Xilio Therapeutics | 31.80M |
| Palatin Technologies | 8.96M |
| CervoMed | 6.16M |
| Lisata Therapeutics | 1.07M |
| Actinium Pharmaceuticals | 90.00K |
VERU News
- 11 hours ago - Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - GlobeNewsWire
- 26 days ago - Veru Inc. (VERU) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th - GlobeNewsWire
- 2 months ago - Veru Inc. (VERU) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - GlobeNewsWire
- 3 months ago - Veru to Report Fiscal Year 2025 Financial Results on December 17th - GlobeNewsWire
- 4 months ago - Veru to Present Two Abstracts at ObesityWeek 2025 - GlobeNewsWire
- 4 months ago - Veru Announces Proposed Public Offering - GlobeNewsWire